ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2025
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • 2020-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "Inflammation"

  • Abstract Number: 0381 • ACR Convergence 2020

    Efficacy of Tofacitinib on Dactylitis in Individual Digits in Patients with Active Psoriatic Arthritis

    Ana-Maria Orbai1, Philip Mease2, Philip Helliwell3, Oliver FitzGerald4, Mohamed Bedaiwi5, Dona Fleishaker6, Rajiv Mundayat6 and Pamela Young7, 1Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Seattle Rheumatology Associates, P.L.L.C., Seattle, WA, 3Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, Leeds, United Kingdom, 4Conway Institute for Biomolecular Research, University College Dublin, Dublin, Ireland, 5Division of Rheumatology, College of Medicine, King Saud University Medical City, King Saud University, Riyadh, Saudi Arabia, 6Pfizer Inc, Groton, CT, 7Pfizer Inc, Collegeville, PA

    Background/Purpose: Dactylitis, a hallmark of psoriatic arthritis (PsA), is a uniformly diffuse and sometimes painful swelling of the fingers and/or toes.1 Up to 50% of…
  • Abstract Number: 0705 • ACR Convergence 2020

    lncRNA H19 and Micro RNA 675-3p Are Altered by Visfatin During Osteogenesis

    Dennis Küppers1, Lali Tsiklauri2, Marie-Lisa Hülser1, Klaus Frommer2, Stefan Rehart3, Caroline Ospelt4, Ulf Müller-Ladner5 and Elena Neumann6, 1Justus-Liebig-University Giessen, Campus Kerckhoff, Dept. of Rheumatology and Clinical Immunology, Giessen, Germany, 2Justus-Liebig-University Giessen, Campus Kerckhoff, Dept. of Rheumatology and Clinical Immunology, Bad Nauheim, Germany, 3Department of Orthopaedics and Trauma Surgery, Agaplesion Markus Hospital, Frankfurt, Frankfurt, Germany, 4University Hospital Zürich; University Hospital of Zurich; Center of Experimental Rheumatology, Department of Rheumatology, Zurich, Switzerland, 5Department of Rheumatology, Immunology, Osteology and Physical Medicine, Justus Liebig University Gießen, Campus Kerckhoff, Bad Nauheim, Germany, Bad Nauheim, Germany, 6Department of Rheumatology and Clinical Immunology, Campus Kerckhoff, Justus Liebig University Giessen, Bad Nauheim, Germany

    Background/Purpose: Long non-coding (lnc-)RNAs are transcribed from DNA similar to mRNA. lncRNA are able to interact directly with DNA, RNA and proteins. Some lncRNAs contain…
  • Abstract Number: 0949 • ACR Convergence 2020

    SLAMF7 Engagement Drives Monocyte Super-Activation in Acute and Chronic Inflammation

    Daimon Simmons1, Hung Nguyen2, Emma Gomez-Rivas3, YunJu Jeong4, William Apruzzese5, Edy Kim6 and Michael Brenner7, 1Department of Pathology, Brigham and Women's Hospital, Boston, MA, 2Division of Rheumatology, Brigham and Women's Hospital,, Boston, MA, 3Division of Rheumatology, Brigham and Women's Hospital, Boston, MA, 4Division of Pulmonary and Critical Care, Brigham and Women's Hospital, Boston, MA, 5., Boston, 6Brigham and Women’s Hospital, Division of Pulmonary and Critical Care Medicine, Boston, MA, 7Brigham and Women's Hospital and Harvard Medical School, Boston, MA

    Background/Purpose: Monocytes orchestrate immune responses that protect against microbes but can also drive pathological inflammation and autoimmune disease. Monocytes are thought to be activated primarily…
  • Abstract Number: 1240 • ACR Convergence 2020

    An Increase in Red Cell Mean Corpuscular Volume by Methotrexate Is Potentiated by Hydroxychloroquine and Predicts Clinical Response in Rheumatoid Arthritis

    Muhammad Shipa1, Su-Ann Yeoh1, Dev Mukerjee2 and Michael Ehrenstein1, 1University College London, LONDON, United Kingdom, 2North Middlesex University hospital NHS Trust, London, United Kingdom

    Background/Purpose: Methotrexate (MTX) can result in an increase in mean corpuscular volume (MCV) of red blood cells. The range of MCV change varies between patients…
  • Abstract Number: 1637 • ACR Convergence 2020

    Comparison of Nation-wide Epidemical Study on 2009 and That on 2019 Revealed That Improvement of Disease Severity and Mortality Rate May Come from Progress of Proficient Management in Patients with Relapsing Polychondritis in Japan

    Jun Shimizu1, Yoshihisa Yamano1, Kimito Kawahata2 and Noboru Suzuki1, 1St. Marianna University School of Medicine, Kawasaki, Japan, 2Division of Rheumatology and Allergology, Department of Internal Medicine, St. Marianna University School of Medicine, Kawasaki, Japan

    Background/Purpose: We conducted a retrospective survey study in 2009 and collected clinical data of 239 patients with relapsing polychondritis (RP). Using the survey data, we…
  • Abstract Number: PP05 • ACR Convergence 2020

    Coping Through Advocacy – My Story Living with Relapsing Polychondritis

    Allegonda Imeson1, 1The Canadian Society for Relapsing Polychondritis, Stony Plain, AB, Canada

    Background/Purpose: Becoming a mother was the most pivotal moment of my life. From early on, I instilled the importance of a physical, healthy lifestyle for my two…
  • Abstract Number: 0015 • ACR Convergence 2020

    COVID -19 Lung Inflammation – What Have We Learnt so Far ?

    Sriya Gokaraju1, Maria Darda2, Vinod Vijayaraghavan Nalini Warrier3, Irina Duta3, Fiona Hayes3, Yasser Ahmed4 and Gouri Koduri3, 1Southend University Hospital NHS Trust, Essex, United Kingdom, 2Southend University Hospital NHS Trust, Essex, United Kingdom, 3Southend University Hospital NHS Trust, Essex, United Kingdom, 4Southend University Hospital, Essex, United Kingdom

    Background/Purpose: The SARS CoV-2 pandemic has inspired new interest in understanding the fundamental pathology of pneumonia and Acute Respiratory Distress Syndrome (ARDS). SARS CoV-2 in…
  • Abstract Number: 0410 • ACR Convergence 2020

    Exploring Gene Expression Profile of Primary Central Nervous System Vasculitis

    Carlo Salvarani1, Robert Brown2, Jonas Paludo2, Stefania Croci3, Stephen Ansell4, Caterina Giannini2, Joseph Parisi2, Kenneth Warrington2 and Gene Hunder2, 1Azienda USL-IRCCS di Reggio Emilia e Università di Modena e Reggio Emilia, Reggio Emilia, Italy, 2Mayo Clinic, Rochester, MN, 3Azienda USL-IRCCS di Reggio Emilia, Reggio Emilia, Italy, 4Mayo Clinic, Rochester

    Background/Purpose: Primary CNS vasculitis (PCNSV) is an uncommon and poorly understood disease that affects the brain and spinal cord. It includes heterogeneous  histopathological patterns,  clinical…
  • Abstract Number: 0706 • ACR Convergence 2020

    Adenosine A2A Receptor Activation Reduces Markers of Chondrocyte Senescence and Cartilage Inflammation Associated with Osteoarthritis

    Benjamin Friedman1 and Bruce Cronstein2, 1NYU Rheumatology, New York, NY, 2NYU Grossman School of Medicine, New York, NY

    Background/Purpose: Osteoarthritis is an aging-associated disorder linked to dysfunctional metabolism, chronic inflammation, oxidative stress, and cellular senescence. Cellular senescence is associated with stable cell cycle…
  • Abstract Number: 0953 • ACR Convergence 2020

    Long-term Xanthine Oxidase Inhibitor Treat to Target Urate Lowering Therapy Coordinately Re-wires the Mononuclear Leukocyte Mitochondrial and Inflammatory Proteome in Gout

    Jacob Wozniak1, Ru Bryan2, David Gonzalez3 and Robert Terkeltaub4, 1UC San Diego, San Diego, CA, 2UCSD, San Diego, CA, 3UC San Diego, San Diego, CO, 4VA Medical Center/UC San Diego, San Diego, CA

    Background/Purpose: In gout, long-term xanthine oxidase inhibitor treat to target urate lowering therapy (XOIT2T) markedly reduces flares and synovitis, despite delayed resolution of tissue crystal…
  • Abstract Number: 1309 • ACR Convergence 2020

    Prevalence of Undiagnosed Axial Spondyloarthritis Among Patients with Inflammatory Bowel Disease: A Secondary Care Cross-Sectional Study

    Chong Seng Edwin Lim1, Mark Tremelling1, Louise Hamilton1, Alexander MacGregor1, Tom Turmezei1, Matthew Kim1 and Karl Gaffney2, 1Norfolk and Norwich University Hospital, Norwich, United Kingdom, 2Norfolk and Norwich University Hospital NHS Foundation Trust, Norfolk, United Kingdom

    Background/Purpose: Axial spondyloarthritis (axSpA) is closely related to inflammatory bowel disease (IBD), however contemporary data on the burden of hidden disease in the IBD population…
  • Abstract Number: 1648 • ACR Convergence 2020

    Comparison of Methotrexate and Glucosamine in Primary Knee Osteoarthritis with Inflammation

    Biswadip Ghosh1, Subhankar Haldar2 and Meghna Saha2, 1IPGME&R, Kolkata, Kolkata, West Bengal, India, 2IPGME&R, Kolkata, KOLKATA, India

    Background/Purpose: Many patients suffering from knee OA show swelling, warmth along with pain which are features of inflammation. There are no accepted pharmacological therapy for osteoarthritis…
  • Abstract Number: PP06 • ACR Convergence 2020

    Only in My Dreams Can I Do the Things I Used to Do: Where There Is Research, There Is Hope

    Dan Smith1, Robert Smith1 and Jillian Covault1, 1Canton, MI

    Background/Purpose: In Mach 2020, I was diagnosed with relapsing polychondritis ("RP"), a multisystem, rheumatologic disease characterized by inflammation of cartilaginous structures including the ear, nose,…
  • Abstract Number: 0065 • ACR Convergence 2020

    The Energy-dependent Hierarchy of Immune Functions in Human Monocytes

    Pierre-Louis Krauß1, Thomas Buttgereit2, Yuling Chen1, Moritz Pfeiffenberger1, Timo Gaber1 and Frank Buttgereit3, 1Charité – Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Rheumatology and Clinical Immunology, Berlin, Germany, 2Charité-Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Department of Dermatology, Venerology, and Allergology, Berlin, Germany, 3Charité University Medicine, Berlin, Germany

    Background/Purpose: At sites of inflammation, monocytes carry out specific immunological functions while facing challenging bioenergetic restrictions. Here, we investigated the potential of human monocytes to…
  • Abstract Number: 0447 • ACR Convergence 2020

    Magnetic Resonance Imaging Characteristics in Patients with Spondyloarthritis and Clinical Diagnosis of Heel Enthesitis: Screening Data from a Phase 3 Trial

    Xenofon Baraliakos1, Philipp Sewerin2, Eugenio De Miguel3, Christine Kleinmond4, Ankita Shekhawat5, Claudia Jentzsch6, Annette Wiedon7 and Frank Behrens8, 1Rheumazentrum Ruhrgebiet Herne, Ruhr-University Bochum, Bochum, Germany, 2Department of Rheumatology & Hiller Research Unit, University Hospital Düsseldorf, Duesseldorf, Germany, 3Rheumatology Department, Hospital Universitario La Paz, Madrid, Spain, 4ClinProject GmbH, Eurasburg, Germany, 5Novartis Healthcare Private Limited, Hyderabad, Telangana, India, 6Novartis Pharma GmbH, Nuremberg, Germany, 7Novartis Pharma GmbH, Nurnberg, Germany, 8CIRI/Rheumatology & Fraunhofer TMP, Goethe University, Frankfurt, Germany

    Background/Purpose: Inflammation and pain at entheseal sites are the key clinical signs in patients (pts) with axial spondyloarthritis (axSpA) and psoriatic arthritis (PsA).1 Magnetic resonance…
  • « Previous Page
  • 1
  • …
  • 43
  • 44
  • 45
  • 46
  • 47
  • …
  • 67
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

Embargo Policy

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM CT on October 25. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology